Improving Hematopoietic Stem Cell Transplant in the Elderly: Can We Finally Start to Impact Nonrelapse Mortality? [0.03%]
改善老年患者的造血干细胞移植：我们是否最终可以影响非复发性死亡率？
Thomas G Knight
Thomas G Knight
Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System Analysis [0.03%]
嵌合抗原受体T细胞疗法与心血管事件相关性: 横断面FDA不良事件报告系统分析
Avirup Guha,Daniel Addison,Prantesh Jain et al.
Avirup Guha et al.
Chimeric antigen receptor (CAR) T cell therapy is approved in the United States for the treatment of acute lymphocytic leukemia and aggressive B cell lymphomas. Multiple cardiovascular adverse events (CVEs) associated with CAR-Ts have been ...
Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age [0.03%]
成人在美国进行造血细胞移植的障碍：系统的综述并聚焦于年龄因素
Colin Flannelly,Bryan E-Xin Tan,Jian Liang Tan et al.
Colin Flannelly et al.
Hematopoietic cell transplantation (HCT) is an effective treatment for many hematologic malignancies, and its utilization continues to rise. However, due to the difficult logistics and high cost of HCT, there are significant barriers to acc...
Patrick Smith,Jillian C Thompson,Elena Perea et al.
Patrick Smith et al.
Delirium is common among adults undergoing hematopoietic stem cell transplantation (HCT), although the clinical and neuroimaging correlates of post-HCT delirium have not been adequately delineated. We therefore examined the frequency of del...
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis [0.03%]
移植后环磷酰胺所致移植物抗宿主病预防治疗后的血栓性微血管病
Philip H Imus,Hua-Ling Tsai,Amy E DeZern et al.
Philip H Imus et al.
Transplant-associated thrombotic microangiopathy (taTMA) is a systemic vascular illness associated with significant morbidity and mortality, resulting from a convergence of risk factors after allogeneic blood or marrow transplantation (allo...
Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel Agents [0.03%]
新型药物时代自体或异基因造血干细胞移植治疗浆细胞白血病的疗效研究
Christopher Lemieux,Laura J Johnston,Robert Lowsky et al.
Christopher Lemieux et al.
Plasma cell leukemia (PCL) is a rare and very aggressive plasma cell disorder. The optimal treatment approach, including whether to pursue an autologous (auto) or allogeneic (allo) stem cell transplantation (SCT) is not clear, given the lac...